Lung ultrasound is a novel diagnostic tool that has revolutionized the way of performing ultrasonography and cardiology based on the interpretation of artifacts and modifying the diagnostic and therapeutic approach of patients with heart diseases. This technique can be performed by the cardiologist with the transducer and screen adjustments used in echocardiography and should recognize four ultrasound patterns: aerated/dry lung, wet or interstitial lung, pleural effusion and consolidation. The interstitial pattern is the basis of the applications of this technique in cardiology, which is summarized in seven clinical settings: differential diagnosis of dyspnea, heart failure syndrome, identification of acute respiratory distress, extreme situations as high altitude pulmonary edema, breath-hold diving and ironman, dialysis patients, acute coronary syndrome and alveolar-capillary stress echo. Developing skills in cardiopulmonary ultrasound should be mandatory and not optional for cardiologists.
INTRODUCTION
Lung ultrasound (LUS) is a novel diagnostic tool that has revolutionized the way of performing ultrasonography and cardiology based on the interpretation of artifacts by optimizing the diagnostic and therapeutic approach of patients with heart disease. (1) The first mention of this technique was made in 2010 in the scientific statement "Assessing and grading congestion in acute heart failure", with the timid comment that "ultrasonography of the lungs using an echocardiographic probe is another potentially useful way to assess pulmonary congestion through the visualization of lung ultrasound comet-tails". (2) In 2012, the document "International evidence-based recommendations for point-of-care lung ultrasound" stated that this technique is a complement more accurate than chest X-rays and compares well with computed tomography scan in most pulmonary and pleural diseases, as it facilitates the diagnosis of heart failure (HF). (3)
In the consensus statement "Echocardiography and lung ultrasonography for the assessment and management of acute heart failure", published in 2017 by the European Society of Cardiology (ESC), this technique attained its appropriate position as a fundamental complement of echocardiography, in an integrated approach of heart and lung assessment, to 
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Superficial improve the evaluation, diagnosis and follow-up of patients with HF and identify those with the worse outcome. (4) In the same year, in the publication "Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management", the ESC stated that LUS: -Is more accurate than auscultation or chest X-ray for the detection of pulmonary congestion. -Serial assessment may be useful for monitoring treatment effects in patients with HF. -Provides a graded measure of pulmonary congestion with high reproducibility after a short training period (30 minutes). -Detects residual pulmonary congestion at discharge of patients with HF, indicating risk for subsequent hospitalizations or death. (5) In 2018, the ESC continued promoting this technique with two documents: 1. "Comprehensive in-hospital monitoring in HF: Applications for clinical practice and future directions for research" indicating that "LUS allows guiding decongestive therapy and may be useful to indicate discharge readiness. (6) 2. "Indications and practical approach to non-invasive ventilation in acute HF" which included findings of ultrasonography signs of pulmonary congestion as diagnostic criteria for confirmation of acute cardiogenic pulmonary edema. (7)
All these publications show that including LUS in cardiology has modified the daily practice of the specialty by allowing an integrated cardio-pulmonary ultrasound assessment in acute and chronic settings, thus optimizing the diagnosis, follow-up and prognosis of patients with cardiac diseases.
TECHNICAL ASPECTS
The cardiologist can use the same probe used for echocardiography, with the same orientation and specifications on the screen. For the exploration, each hemithorax is divided into six regions. Using the anatomic landmarks set by the anterior and posterior axillary lines, three regions are determined: anterior, lateral and posterior. Each region is divided in superior and inferior using the inter-nipple and subscapular lines. The transducer is placed perpendicular to the chest wall, with the probe indicator toward the patient's head (longitudinal approach). In this way, the superficial structures are visualized at the top of the screen with the cranial structures at the right ( Figure 1 ). (8)
ULTRASOUND IMAGE
After placing the transducer on the anterior or superior regions, the following structures shown in Figure  2A are visualized: a. Superficial structures of the chest wall, from surface to depth: Figure 2B ). c. Sub-pleural space or pulmonary ultrasound window: Space immediately below the pleural line. Artifacts are seen when air is the predominant component and real images are visualized if the lung is mostly filled with fluid.
The cardiologist must recognize four ultrasound patterns:
Aerated/dry lung Interstitial pattern or wet lung Pleural effusion Lung consolidation Each pattern represents a different balance between air and fluid and indicates the degree of aerated lung. (9)
Aerated/dry lung pattern:
This pattern corresponds to lung aeration of 99% and has the following characteristic signs: • "Lung sliding sign". • "Seashore sign" • A lines.
With 99% lung aeration, the ultrasound beam penetrating the chest wall reflects the interface between the pleura and the aerated lung tissue generating A lines, which represent horizontal reverberation artifacts parallel to the pleural line, vanish in depth and are equidistant to the space between the skin and the pleural line. In this pattern, the subpleural space is represented as a hypoechoic area with A lines, and corresponds to normal lungs or air trapping in diseases as COPD and asthma ( Figure 3A ).
Wet lung pattern, interstitial pattern or interstitial syndrome
This pattern is present with lung aeration of 95%-97% (3%-5% of fluid) and is characterized by the presence of B lines ( Figure 3B ). In the lung, fluid initially accumulates in the interstitial space (interlobular and intralobular septa surrounded by alveoli). The ultrasonic beam interacts with the interface between the pleural line and interstitial fluid (fluid or inflammatory cells), and is transmitted to the interstitial space, and reflected in the interface between the pleural line and alveolar air, generating artifacts called "B lines" with the following six characteristics 
Pleural effusion pattern
This pattern corresponds to 100% fluid in the subpleural space. It is identified as an area of variable echogenicity, usually anechoic ( Figure 4) . The lower areas of the thorax should be explored to assess it and the liver or spleen can be used as acoustic window. Once these solid organs are located, the cranial hyperechoic border corresponding to the diaphragm is identified, and everything cephalic to it corresponds to the thorax. Once the thorax is detected, the anechoic area corresponds to pleural effusion. Pleural effusion is classified and quantified by ultrasound. The classification is based on the presence of echogenic images within the effusion. Simple effusions are anechoic and are usually transudates. Complex effusions with echogenic spots or septa strains are exudates in 100% of the cases. (11) There are several ways of quantification in the sitting position and supine position, but all of them inaccurate; however, they give an idea of the amount of fluid and provide a way of monitoring. One of the most convenient ways of quantification is Bialik's formula. With the patient in the supine position with trunk elevation at 15°, the maximal distance between parietal and visceral pleura is measured in end-expiration and multiplied by 20 to obtain an approximate amount of pleural fluid. (12) 
Lung consolidation pattern
This pattern is present with lung aeration <10%, so the lung is predominantly fluid filled and the images seen are predominantly real ( Figure 5) . The lung is seen as a tissue-like structure in echogenicity closely resembling the liver. This pattern is commonly seen in pneumonia, atelectasis, pulmonary infarction, tumors or contusions. The diagnosis is based on the different characteristics of the "tissue-like sign", such as the presence of internal components, homogeneity, margins, vascularization and changes with breathing or different positions. The cardiologist should recognize this pattern to rule out pneumonia as a cause of decompensated HF.
CLINICAL APPLICATIONS
The use of LUS in cardiology is mainly based on identifying the wet lung pattern or interstitial syndrome, and can be summarized in seven clinical situations: (13) 1. Dyspnea. Lichtenstein was one of the first to apply LUS for dyspnea. He described that B lines could differentiate acute cardiogenic pulmonary edema from exacerbation of COPD. (14) In 2008, Lichten- 
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Diaphragm Abdomen Thorax Lung stein described the BLUE protocol for patients with respiratory failure, in which LUS was used to guide the diagnosis with an accuracy of 90.4%. (15) In patients with dyspnea/respiratory failure, the aerated/dry lung pattern directs the diagnosis towards conditions with air trapping such as COPD or asthma. The wet lung pattern suggests cardiogenic or non-cardiogenic pulmonary edema (acute respiratory distress) or interstitial conditions such as interstitial lung disease or interstitial pneumonitis. A pleural effusion pattern can be classified as simple/complex or unilateral/bilateral, and suggests a systemic or local disease. Finally, a consolidation pattern orientates towards the diagnosis of pneumonia. atelectasis, tumors or pulmonary infarction. Thus, LUS not only provides differential diagnoses of the causes of dyspnea but also gives information on the possible causes of decompensation in cardiac patients. Nowadays, LUS is an important first-line modality in the primary evaluation of acute dyspnea. (16) hipoechoic nodules below the pleural line (frag mented pleural line). 3. "Spared areas": areas of dry lung pattern surrounded by areas of multiple B-lines within the same intercostal space. This syndrome is produced by abnormalities in alveolar-capillary permeability. In HF, pulmonary congestion is due to increased hydrostatic pressure leading to transudation of fluid into the pulmonary interstitium and then into the alveoli. In ARDS, interstitial and alveolar edema occur simultaneously. 4. Pulmonary edema in extreme settings as high altitude pulmonary edema, after apnea diving and ironman triathlon. (20, 21) High altitude pulmonary edema occurs at heights above 2500 m and is due to hypobaric hypoxia which produces pulmonary hypertension. Lung ultrasound is useful for the evaluation of climbers during their ascent to high altitudes in the different points of ascent in order to delay those who present B lines until they disappear, indicating adaptation. In divers, pulmonary edema after apnea is caused by significant blood volume shift from the peripheral to the central circulatory system, with a non-negligible prevalence of 25% to 45% (associated with genetic predisposition). The prevalence of asymptomatic pulmonary edema until 12 hours after the race has been described in up to 75% of ironman athletes. 5. In chronic kidney failure patients, LUS is particularly useful for the evaluation of dyspnea during dialysis for the early diagnosis of pulmonary congestion in asymptomatic patients. As the number of B lines decreases with dialysis, the use of LUS between dialyses has prognostic implications because the presence of B lines constitutes a risk factor for cardiovascular events and mortality. (22) 6. Acute coronary syndrome. Dr. Gargani was the first to describe ejection fraction, TAPSE and ultrasound lung comet-tails (former name of the B lines) as the only independent predictors of mortality. (23) In acute coronary syndrome, LUS provides:
• Early diagnosis of pulmonary edema.
• Prognosis and risk stratification: Patients with B lines are at higher risk of complications and mortality. 7. Alveolar-capillary stress echo. The presence of B lines at peak stress can evaluate the competence of the alveolar-capillary membrane. Within the first minutes after peak stress, hemodynamic congestion is evaluated by the E/e' ratio and the presence of B lines indicate pulmonary congestion. In the "Stress echo 2020 project for the study of ischemic and non-ischemic heart disease", Picano et al. proposed ten protocols, five of which included the assessment of B lines. (24) In light of the evidence, LUS has become a mandatory learning method for the cardiologist, as an indispensable complement to echocardiography which, as an integrated cardiopulmonary ultrasound evaluation, optimizes the diagnosis, treatment, follow-up and prognosis of patients with ischemic, non-ischemic, acute and chronic heart diseases.
